Costing the implementation of public health interventions in resource-limited settings: a conceptual framework

by Hojoon Sohn, Austin Tucker, Olivia Ferguson, Isabella Gomes, David Dowdy
Published 2020-09-01

Informing decision-making for universal access to quality tuberculosis diagnosis in India: an economic-epidemiological model

by Hojoon Sohn, Parastu Kasaie, Emily Kendall, Gabriela B. Gomez, Anna Vassall, Madhukar Pai, David Dowdy
Published 2019-08-01

Standardized framework for evaluating costs of active case-finding programs: An analysis of two programs in Cambodia and Tajikistan.

by Youngji Jo, Farangiz Mirzoeva, Monyrath Chry, Zhi Zhen Qin, Andrew Codlin, Oktam Bobokhojaev, Jacob Creswell, Hojoon Sohn
Published 2020-01-01

Impact of Molecular Diagnostics for Tuberculosis on Patient-Important Outcomes: A Systematic Review of Study Methodologies.

by Samuel G Schumacher, Hojoon Sohn, Zhi Zhen Qin, Genevieve Gore, J Lucian Davis, Claudia M Denkinger, Madhukar Pai
Published 2016-01-01

Evaluating the impact of the nationwide public-private mix (PPM) program for tuberculosis under National Health Insurance in South Korea: A difference in differences analysis.

by Sarah Yu, Hojoon Sohn, Hae-Young Kim, Hyunwoo Kim, Kyung-Hyun Oh, Hee-Jin Kim, Haejoo Chung, Hongjo Choi
Published 2021-07-01

Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016 [version 2; referees: 4 approved]

by Danielle Cazabon, Tripti Pande, Sandra Kik, Wayne Van Gemert, Hojoon Sohn, Claudia Denkinger, Zhi Zhen Qin, Brenda Waning, Madhukar Pai
Published 2018-09-01

Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016 [version 1; referees: 4 approved]

by Danielle Cazabon, Tripti Pande, Sandra Kik, Wayne Van Gemert, Hojoon Sohn, Claudia Denkinger, Zhi Zhen Qin, Brenda Waning, Madhukar Pai
Published 2018-07-01

Cost and operational impact of promoting upfront GeneXpert MTB/RIF test referrals for presumptive pediatric tuberculosis patients in India.

by Sanjay Sarin, Sophie Huddart, Neeraj Raizada, Debadutta Parija, Aakshi Kalra, Raghuram Rao, Virender Singh Salhotra, Sunil D Khaparde, Catharina Boehme, Claudia M Denkinger, Hojoon Sohn
Published 2019-01-01

Operational characteristics of antiretroviral therapy clinics in Zambia: a time and motion analysis

by Radhika P. Tampi, Taniya Tembo, Mpande Mukumba-Mwenechanya, Anjali Sharma, David W. Dowdy, Charles B. Holmes, Carolyn Bolton-Moore, Izukanji Sikazwe, Austin Tucker, Hojoon Sohn
Published 2019-04-01

The Sensitivity and Specificity of Loop-Mediated Isothermal Amplification (LAMP) Assay for Tuberculosis Diagnosis in Adults with Chronic Cough in Malawi.

by Marriott Nliwasa, Peter MacPherson, Palesa Chisala, Mercy Kamdolozi, McEwen Khundi, Kruger Kaswaswa, Mphatso Mwapasa, Chisomo Msefula, Hojoon Sohn, Clare Flach, Clare Flach, Elizabeth L Corbett
Published 2016-01-01

An integrated approach to rapid diagnosis of tuberculosis and multidrug resistance using liquid culture and molecular methods in Russia.

by Yanina Balabanova, Francis Drobniewski, Vladyslav Nikolayevskyy, Annika Kruuner, Nadezhda Malomanova, Tatyana Simak, Nailya Ilyina, Svetlana Zakharova, Natalya Lebedeva, Heather L Alexander, Rick O'Brien, Hojoon Sohn, Anastasia Shakhmistova, Ivan Fedorin
Published 2009-09-01

Cost-effectiveness comparison of Genechip and conventional drug susceptibility test for detecting multidrug-resistant tuberculosis in China.

by Yu Pang, Qiang Li, Xichao Ou, Hojoon Sohn, Zhiying Zhang, Junchen Li, Hui Xia, Kai Man Kam, Richard J O'Brien, Junying Chi, Shitong Huan, Daniel P Chin, Yan-lin Zhao
Published 2013-01-01

Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis.

by Anna Vassall, Sanne van Kampen, Hojoon Sohn, Joy S Michael, K R John, Saskia den Boon, J Lucian Davis, Andrew Whitelaw, Mark P Nicol, Maria Tarcela Gler, Anar Khaliqov, Carlos Zamudio, Mark D Perkins, Catharina C Boehme, Frank Cobelens
Published 2011-11-01

Study protocol: a cluster randomized trial to evaluate the effectiveness and implementation of onsite GeneXpert testing at community health centers in Uganda (XPEL-TB)

by Tania F. Reza, Talemwa Nalugwa, Katherine Farr, Mariam Nantale, Denis Oyuku, Annet Nakaweesa, Johnson Musinguzi, Moksha Vangala, Priya B. Shete, Austin Tucker, Olivia Ferguson, Katherine Fielding, Hojoon Sohn, David Dowdy, David A. J. Moore, J. Lucian Davis, Sara L. Ackerman, Margaret A. Handley, Achilles Katamba, Adithya Cattamanchi
Published 2020-04-01

Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluation

by Anil Pooran, PhD, Grant Theron, PhD, Lynn Zijenah, PhD, Duncan Chanda, MD, Petra Clowes, MD, Lawrence Mwenge, MSc, Farirai Mutenherwa, MSc, Paul Lecesse, MD, John Metcalfe, MD, Hojoon Sohn, PhD, Michael Hoelscher, MD, Alex Pym, PhD, Jonny Peter, PhD, David Dowdy, PhD, Keertan Dheda, PhD
Published 2019-06-01